Abstract Details
|
Elizabeth T. Troy, MD
(University of Colorado)
PRESENTER |
The institution of Dr. Troy has received research support from ABPN. The institution of Dr. Troy has received research support from 好色先生. Dr. Troy has received publishing royalties from a publication relating to health care. Dr. Troy has received publishing royalties from a publication relating to health care. |
| Timothy Bernard, MD (U of Colorado Denver and Children's Hospital) | The institution of Dr. Bernard has received research support from NIH. |
| John Binder, MD (Billings Clinic) | Dr. Binder has nothing to disclose. |
| Aaron M. Carlson, MD (University of Colorado, School of Medicine, Department of Neurology) | Dr. Carlson has received research support from Horizon Therapeutics (Amgen). |
| Hannah Gilbert, MD | Dr. Gilbert has nothing to disclose. |
| Jan A. Martin, MD (University of Washington/Seattle Children's Hospital) | Dr. Martin has nothing to disclose. |
| Jeremy Moeller, MD, FAAN (Yale University) | Dr. Moeller has received publishing royalties from a publication relating to health care. |
| Scott Rosenthal, MD (University of Colorado) | Dr. Rosenthal has a non-compensated relationship as a Sub-Investigator with Biohaven and Teva that is relevant to AAN interests or activities. |
| Michelle Tutmaher, DO (Children's Hospital Colorado) | Dr. Tutmaher has nothing to disclose. |
| TAI M. LOCKSPEISER, MD | Dr. LOCKSPEISER has nothing to disclose. |